N2OFF Inc Shares Climb Following Encouraging Preliminary Study on New Anti-Inflammatory Therapies
N2OFF Inc, listed as NITO on NASDAQ, saw its premarket stock price rise by 17.6% after unveiling early-stage findings indicating its subsidiary MitoCareX Bio's small-molecule drugs may effectively inhibit inflammation in human immune cells. The company is leveraging its MITOLINE™ platform to model mitochondrial carriers critical for addressing infl…